Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (7135)	5/24/2001 2:05:39 AM
From: Libbyt	Read Replies (1) \| Respond to of 57684

Anyone following Genome? I haven't followed some of the biotech companies for awhile, but the volume in GENE caught my attention! I went back and did some research on the company, since I remember discussing GENE about 18 months ago? (can't remember the exact timing.) At the time, quite a few people were investing in CRA, and at the time IMO GENE offered an advantage when compared to other companies involved with genetic research. GENE is involved with gene sequencing of bacteria and viruses. Their research attempts to discover the drugs and chemicals that alter and kill the bacteria or virus. This research information on the sequencing of genes can then be sold to the large pharmaceutical companies The pharmaceutical company then uses this information to try to develop new antibiotics. Compared to other companies, the risk of developing the actual drugs is to the pharmaceutical companies, and not to GENE...since they are providing the research, and not the actual development of the drugs. It sounds like a case of "dueling analysts"....with two different opinions on this company, but IMO compared to some of the other companies dealing with genetic research, GENE seems to offer a lot of potential.

To: Bill Harmond who wrote (7135)	5/24/2001 2:18:41 AM
From: craig crawford	Read Replies (2) \| Respond to of 57684

>> Yeah, right. << Not out of the realm of possibility. Of course they might sell out before that happens but at much lower levels. Perhaps they will emerge out of bankruptcy and then be bought. You never did answer my question. Do you believe the government manipulates the data to make inflation seem artificially low?

To: Bill Harmond who wrote (7135)	5/24/2001 8:52:34 AM
From: craig crawford	Respond to of 57684

The part in bold is total hogwash! I like how brazen he is. A Load of Bull -- for a Few Months at Least By Aaron L. Task Senior Writer 5/22/01 7:42 PM ET thestreet.com "Earlier this month, the 13-week annualized growth rate of MZM money supply was at 28%, Hays noted with astonishment" Whereas inflation contributed to the economic (and market) downturn of 1981-82, "there is no chance -- zero -- of any significant inflation popping back up" today, Hays argued. "Inflation will peak in the next three months and come plunging back down again in the next 12 to 24 months because of [the deflationary forces of] globalization and the technology revolution." Additionally, the Fed's solution to a string of problems -- from the 1987 crash, to the S&L crisis, to Long Term Capital Management, to Y2K, to the recent bursting of the Nasdaq bubble -- has been "to print money and [Alan] Greenspan has been a central player," Hathaway recalled. "Sooner or later he's only compounding the mistakes. When the chickens come home to roost, you can't put the toothpaste back in the tube. That's why you might want to have some exposure to the [yellow] metal."

To: Bill Harmond who wrote (7135)	5/24/2001 9:04:00 AM
From: craig crawford	Respond to of 57684

Thursday May 24 3:25 AM ET Middle East Fighting Rages Despite Truce Call dailynews.yahoo.com

To: Bill Harmond who wrote (7135)	5/24/2001 10:35:13 AM
From: craig crawford	Respond to of 57684

Citigroup's Rubin Skeptical Of US Econ Recovery In Q4 quicken.excite.com Updated: Tuesday, May 22, 2001 09:57 PM ET Rubin cited an expectation among many economists that "in the fourth quarter the U.S. will be back on a healthy track, but there's a reasonable chance these difficulties will be longer than we would wish." Among the other "excesses" that continue to trouble the economy are the stock market, which "has been at levels that were absurdly high," and a previous buildup of business investments.